Mapping regulatory information throughout the human genome is essential for both determining the function of the human genome and for understanding human development and disease. We propose to establish a high throughput production facility to identify the DNA binding sites for transcription factors and chromatin modifying proteins in human cells. Transcription factor targets, chromatin modifications and modifying enzymes will be mapped across the genome using chromatin immunoprecipitation experiments. This binding information will be validated and analyzed to ensure that it is of high quality and then compared to other genomic annotations. Our three aims are: 1) To establish a production facility for mapping targets of transcription factors. The pipeline will consist of five components: a) cell preparation, b) antibody validation and chromatin immunoprecipitation, c) DNA target analysis, d) target validation and e) sample tracking and databases. 2) To use the pipeline to map targets of 600 transcription factors, chromatin modifications and chromatin modifying enzymes in at least two major cell lines (HeLa S3 and HepG2), and targets of other factors in additional cell lines. 3) To maintain our results in a database and also make them accessible through public databases. We will interrelate our genomic annotations with those determined by other groups (particularly those from the ENCODE consortium), focusing on correlating patterns of transcription-factor binding and chromatin modifications with gene expression. We expect this project to contribute significant information to the identification of regulatory and functional elements in the human genome.

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54HG004558-05
Application #
7884605
Study Section
Special Emphasis Panel (ZHG1-HGR-M (O1))
Program Officer
Feingold, Elise A
Project Start
2007-09-28
Project End
2013-06-30
Budget Start
2010-07-01
Budget End
2013-06-30
Support Year
5
Fiscal Year
2010
Total Cost
$3,123,897
Indirect Cost
Name
Stanford University
Department
Genetics
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Buenrostro, Jason D; Wu, Beijing; Litzenburger, Ulrike M et al. (2015) Single-cell chromatin accessibility reveals principles of regulatory variation. Nature 523:486-90
Wu, Linfeng; Snyder, Michael (2015) Impact of allele-specific peptides in proteome quantification. Proteomics Clin Appl 9:432-6
Boyle, Alan P; Araya, Carlos L; Brdlik, Cathleen et al. (2014) Comparative analysis of regulatory information and circuits across distant species. Nature 512:453-6
Buenrostro, Jason D; Araya, Carlos L; Chircus, Lauren M et al. (2014) Quantitative analysis of RNA-protein interactions on a massively parallel array reveals biophysical and evolutionary landscapes. Nat Biotechnol 32:562-8
Frietze, Seth; O'Geen, Henriette; Littlepage, Laurie E et al. (2014) Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha. BMC Genomics 15:520
Kuleshov, Volodymyr; Xie, Dan; Chen, Rui et al. (2014) Whole-genome haplotyping using long reads and statistical methods. Nat Biotechnol 32:261-266
Xie, Dan; Boyle, Alan P; Wu, Linfeng et al. (2013) Dynamic trans-acting factor colocalization in human cells. Cell 155:713-24
Hardee, Jennifer; Ouyang, Zhengqing; Zhang, Yuping et al. (2013) STAT3 targets suggest mechanisms of aggressive tumorigenesis in diffuse large B-cell lymphoma. G3 (Bethesda) 3:2173-85
Tilgner, Hagen; Raha, Debasish; Habegger, Lukas et al. (2013) Accurate identification and analysis of human mRNA isoforms using deep long read sequencing. G3 (Bethesda) 3:387-97
Fleming, Joseph D; Pavesi, Giulio; Benatti, Paolo et al. (2013) NF-Y coassociates with FOS at promoters, enhancers, repetitive elements, and inactive chromatin regions, and is stereo-positioned with growth-controlling transcription factors. Genome Res 23:1195-209

Showing the most recent 10 out of 42 publications